Sander van Deventer – Biography

Last update: 27 days ago

Executive profile

Sander was Chief Scientific Officer at Porton Biologics, and Executive Vice President, Research and Product Development at UniQure. Sander van Deventer joined VectorY Therapeutics in 2021. Sander served as Co-Founder and Chief Technology Officer at VectorY Therapeutics.

Sander van Deventer is currently

Create your alert
to follow the career of Sander van Deventer.

Education

In 2004, Sander van Deventer completed a PhD in Internal Medicine and Gastroenterology at University of Amsterdam.

They have also studied at University of Amsterdam :

Find more alumni from University of Amsterdam

More about Sander van Deventer

Do you need to know more about Sander van Deventer? More results.

Participate
Social media

The colleagues of Sander van Deventer

Company Colleagues
Industry Colleagues
  • In the Biotechnology industry, Sander van Deventer has 35,757 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Sander van Deventer.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard,
and ask for Sander van Deventer.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board